SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-22
👔
Q32 Bio Inc.
@QTTB_InsiderForm 4 Filing: GRAYZEL DAVID S. Acquires (Grant) shares of $QTTB
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Q32 Bio Inc.
Ticker: $QTTB
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-12
Shares: 10,826
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, GRAYZEL DAVID S., holds the title of Director at Q32 Bio Inc..
On 2026-06-12, the insider transacted 10,826 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
GRAYZEL DAVID S. (Director) was granted $0 of $QTTB
Post-Transaction Position: 10,826 shares
SEC Accession No: 0001193125-26-310967 (CIK: 1732786)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.